Equities

Universal Health Realty Income Trust

Universal Health Realty Income Trust

Actions
  • Price (EUR)39.72
  • Today's Change0.56 / 1.43%
  • Shares traded128.00
  • 1 Year change+8.30%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Universal Health Realty Income Trust had net income fall -27.02% from 21.10m to 15.40m despite a 5.46% increase in revenues from 90.63m to 95.58m. An increase in the cost of goods sold as a percentage of sales from 30.56% to 31.92% was a component in the falling net income despite rising revenues.
Gross margin69.95%
Net profit margin18.41%
Operating margin18.41%
Return on assets3.05%
Return on equity9.27%
Return on investment3.18%
More ▼

Cash flow in USDView more

In 2023, Universal Health Realty Income Trust increased its cash reserves by 7.85%, or 598.00k. The company earned 42.94m from its operations for a Cash Flow Margin of 44.93%. In addition the company used 19.11m on investing activities and also paid 23.23m in financing cash flows.
Cash flow per share3.33
Price/Cash flow per share12.80
Book value per share13.12
Tangible book value per share12.56
More ▼

Balance sheet in USDView more

Universal Health Realty Income Trust has a Debt to Total Capital ratio of 66.92%, a lower figure than the previous year's 171.57%.
Current ratio--
Quick ratio--
Total debt/total equity2.02
Total debt/total capital0.6692
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)4.22%
Div growth rate (5 year)1.45%
Payout ratio (TTM)165.99%
EPS growth(5 years)-8.76
EPS (TTM) vs
TTM 1 year ago
4.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.